トピックス
JCOG肝胆膵グループ JCOG1611の主解析論文がJournal of Clinical Oncology (IF: 41.9)に掲載されました
論文・学会発表- JCOG肝胆膵グループ JCOG1611の主解析論文がJournal of Clinical Oncology (IF: 41.9)に掲載されました
- Ohba A, Ozaka M, Mizusawa J, Okusaka T, Kobayashi S, Yamashita T, Ikeda M, Yasuda I, Sugimori K, Sasahira N, Ikezawa K, Miki I, Okano N, Mizuno N, Furukawa M, Shirakawa H, Sano Y, Katayama H, Furuse J, Ueno M, Hepatobiliary, Pancreatic Oncology Group of the Japan Clinical Oncology G. Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial. J Clin Oncol. 2025 Jul 28:JCO2400936.